A consultation process is underway. The report sets out recommendations from the independent CEMIPP group that was set up by the government to consider whether the method for appraising cost effectiveness of vaccination programmes should change. Why?
“In 2014, after considering whether or not vaccination should be introduced to protect children against meningococcal disease group B, the JCVI asked that the methodology they use to appraise vaccination programmes be reviewed to see if the rules for determining the cost-effectiveness of new or existing programmes should differ from those used for appraising other health-related activities that use public resources.
The Cost-Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP) group was set up as a result. It was chaired by John Cairns, a professor of health economics at the London School of Hygiene and Tropical Medicine, and consisted of other academic health economists as well as representatives from bodies such as the JCVI and NICE and analysts from the Department of Health and Social Care and Public Health England. Some stakeholders, including the pharmaceutical industry and some charities, also had an opportunity to feed in views.
The CEMIPP group considered whether there are ways in which the economic evaluation of immunisation programmes differ sufficiently from that of other health related activities using public resources such that the methods for appraising costeffectiveness in vaccination should differ to those used for the wider health system. This independent group submitted its report to the Department in July 2016”
The consultation closes on the 21st May.
